Latest News
-

Unlocking the Potential of Antibodies as a Therapy for Huntington’s Disease
Antibodies are known for their role in immunity, but researchers repurpose them in many ways. Can they be used in HD?
-

Drug Improves Huntington’s Symptoms in Mice – and Their Offspring
HD drug changes DNA folding across generations
-

mTORC1 tips the scales in Huntington’s disease mice
Weighing the scales on mTORC1: A possible new target for HD therapeutics?
-

Can this synthetic oil help feed the brain in Huntington's disease?
A new study shows a synthetic oil called triheptanoin changes how HD brains use energy. But will it help HD?
-

Positive results announced for re-worked tetrabenazine drug in Huntington's disease
Modified 'heavy hydrogen' form of tetrabenazine appears safe and effective for chorea in Huntington's disease
-

Turning skin cells into brain cells: a Huntington's disease research breakthrough?
Scientists can now change human skin cells into working neurons, like the ones that are most affected in HD.
-

Huntington's disease clinical trial announcement: huntingtin-lowering drug to enter Phase I trial in 2015
A clinical trial for an exciting therapy against HD is planned for 2015. The first step is to make sure it is safe.
-

Largest creatine clinical trial for Huntington's disease halted after 'futility' analysis
CREST-E, a trial of the supplement creatine, has been stopped after an early analysis found it couldn't show benefit
-

Should we worry about a huntingtin invasion?
Cool lab experiments show the huntington's disease protein jumping between cells. Does this matter for HD patients?
-

EuroBuzz 2014 Video, day one
Video of our first live session at the European Huntington's Disease Network Meeting.
HDBuzz Trial Tracker
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
Additional insights from Phase 2 study results and update on plans for Phase 3 trial for votoplam
Updates from the ongoing placebo-controlled Phase 2/3 FALCON-HD trial
Previously featured
-
Worms to the Rescue: Separating the Good, the Bad, and the Clumpy Huntingtin
-
January 2026: This Month in Huntington’s Disease Research
-
Phase 1 results announced for Skyhawk’s drug SKY-0515
-
Huntington’s Disease Community Advocacy Helps Land Critical FDA Meeting for AMT-130
-
Better Sleep, Better Function: New Study Links Sleep Quality to Clinical Outcomes in Huntington’s Disease
Follow HDBuzz
Sign up to our monthly email summary by entering your email address on our mailing list page.
Suggest an article
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.
